These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11338922)

  • 41. Bibliography. Current awareness. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):i-xvi. PubMed ID: 19086134
    [No Abstract]   [Full Text] [Related]  

  • 42. Current literature in. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2002; 11(1):79-94. PubMed ID: 11998557
    [No Abstract]   [Full Text] [Related]  

  • 43. Current awareness. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):i-xiv. PubMed ID: 20443219
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk assessment of drugs, biologics and therapeutic devices: present and future issues.
    Centers for Education and Research on Therapeutics Risk Assessment Workshop
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):653-62. PubMed ID: 14762981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [More transparency in drug safety].
    Saussele T
    Med Monatsschr Pharm; 2009 Sep; 32(9):325. PubMed ID: 19795694
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):523-38. PubMed ID: 14513666
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):341-56. PubMed ID: 12812015
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):699-714. PubMed ID: 14762987
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2001; 10(6):561-76. PubMed ID: 11828841
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2002; 11(5):421-36. PubMed ID: 12271887
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2001; 10(2):173-88. PubMed ID: 11499857
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmaceutical risk management: a call to arms for pharmacoepidemiology.
    Hyslop DL; Read HA; Masica DN; Kotsanos JG
    Pharmacoepidemiol Drug Saf; 2002; 11(5):417-20. PubMed ID: 12271886
    [No Abstract]   [Full Text] [Related]  

  • 53. A multiattribute model for evaluating the benefit-risk profiles of treatment alternatives.
    Felli JC; Noel RA; Cavazzoni PA
    Med Decis Making; 2009; 29(1):104-15. PubMed ID: 18812582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug safety. Notes about surveillance].
    Moreno Alvarez PJ; Madurga Sanz M
    Farm Hosp; 2004; 28(3):225-8. PubMed ID: 15222877
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug use investigation (DUI) and prescription-event monitoring in Japan (J-PEM).
    Tanaka K; Morita Y; Kawabe E; Kubota K
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):653-8. PubMed ID: 11980256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Cuban experience in focusing pharmaceuticals policy to health population needs: initial results of the National Pharmacoepidemiology Network (1996-2001).
    Diogène E; Pérez PJ; Figueras A; Furones JA; Debesa F; Laporte JR;
    Pharmacoepidemiol Drug Saf; 2003; 12(5):405-7. PubMed ID: 12899116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction: a survey of international ethics practices in pharmacoepidemiology and drug safety.
    Merz JF
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):579-81. PubMed ID: 11980243
    [No Abstract]   [Full Text] [Related]  

  • 59. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 60. An aviation perspective of safety in the pharmaceutical sector.
    Krokstad T; Edwards B
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):738-40. PubMed ID: 18327853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.